{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:27:44Z","timestamp":1648978064587},"reference-count":13,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.3892\/etm.2010.143","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T21:49:43Z","timestamp":1282859383000},"page":"943-946","source":"Crossref","is-referenced-by-count":2,"title":["Schedule-dependent synergistic effect of rituximab on methotrexate chemotherapy against lymphoma of the central nervous system"],"prefix":"10.3892","volume":"1","author":[{"given":"JUYOUN","family":"JIN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYEUNG MIN","family":"JOO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOONHEE","family":"NAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAE HYUN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SE JEONG","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MI-YOUNG","family":"JO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUNGGEON","family":"JIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HYEONG-SEOK","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOO WON","family":"SEO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEOK JIN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DO-HYUN","family":"NAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WON SEOG","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"key20180108131620_b1-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20180108131620_b2-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J Clin Oncol"},{"key":"key20180108131620_b3-etm-01-06-0943","first-page":"1549","article-title":"Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents","volume":"4","author":"Neuwelt","year":"1998","journal-title":"Clin Cancer Res"},{"key":"key20180108131620_b4-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1227\/01.NEU.0000097715.11966.8E","article-title":"Mechanisms of disease: the blood-brain barrier","volume":"54","author":"Neuwelt","year":"2004","journal-title":"Neurosurgery"},{"key":"key20180108131620_b5-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.20495","article-title":"NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report","volume":"57","author":"Herrlinger","year":"2005","journal-title":"Ann Neurol"},{"key":"key20180108131620_b6-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","article-title":"Treatment for primary CNS lymphoma: the next step","volume":"18","author":"Abrey","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180108131620_b7-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108131620_b8-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/01.WNL.0000137050.43114.42","article-title":"Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide","volume":"63","author":"Enting","year":"2004","journal-title":"Neurology"},{"key":"key20180108131620_b9-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cncr.20339","article-title":"Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas","volume":"101","author":"Wong","year":"2004","journal-title":"Cancer"},{"key":"key20180108131620_b10-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1215\/15228517-2008-119","article-title":"Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma","volume":"11","author":"Jahnke","year":"2009","journal-title":"Neuro Oncol"},{"key":"key20180108131620_b11-etm-01-06-0943","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/foc.2006.21.5.15","article-title":"Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model","volume":"21","author":"Wang","year":"2006","journal-title":"Neurosurg Focus"},{"key":"key20180108131620_b12-etm-01-06-0943","first-page":"436","article-title":"Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat","volume":"146","author":"Barnett","year":"1995","journal-title":"Am J Pathol"},{"key":"key20180108131620_b13-etm-01-06-0943","first-page":"1831","article-title":"Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts","volume":"35","author":"Neuwelt","year":"1994","journal-title":"J Nucl Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2010.143\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T23:10:07Z","timestamp":1515453007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2010.143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,8,26]]},"published-print":{"date-parts":[[2010]]}},"alternative-id":["10.3892\/etm.2010.143"],"URL":"https:\/\/doi.org\/10.3892\/etm.2010.143","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}